Q32 Bio Inc. (QTTB) investors disclose 5.49% stake in Schedule 13G/A
Q32 Bio Inc. (QTTB) disclosed in a Schedule 13G/A that Opaleye, L.P., Opaleye Management Inc., and James Silverman beneficially own 931,000 shares of its common stock, or 5.49%, based on 16,956,415 shares outstanding as of May 1, 2026. The filing attributes shared voting and dispositive power to the group and includes a beneficial-ownership disclaimer.
How this was made
The 30-second read
Why it matters
A 5.49% beneficial ownership disclosure can matter for monitoring potential influence, but it does not provide new company performance, guidance, or deal terms.
Market read
Traders may use the disclosure to update ownership maps, but the text lacks transaction direction or new fundamentals, so expected impact is modest.
What to watch
The article does not state whether this is an increase, decrease, or new position versus prior filings, which limits inference about momentum or control changes.
Background
The article summarizes a Schedule 13G/A beneficial ownership filing for Q32 Bio Inc., listing Opaleye, L.P., Opaleye Management Inc., and James Silverman as reporting persons.
Ticker impact
Q32 Bio Inc. disclosed in a Schedule 13G/A that Opaleye and James Silverman beneficially own 931,000 shares, or 5.49% of the class.
Likely limited near-term impact; any move would be driven by trader interpretation of accumulation rather than new fundamentals.
The filing provides ownership size and voting/dispositive power (shared) but no transaction details, price, or company-specific catalyst beyond the disclosure itself.
Market effects
Minimal, since the disclosure does not change biotech sector fundamentals or regulatory/clinical timelines.
None indicated.
None indicated.
Counterpoint
The stake could be passive or already established, so traders may overreact to the headline percentage without evidence of fresh buying.
Key entities
- issuerQ32 Bio Inc.
Subject of the Schedule 13G/A beneficial ownership disclosure.
- reporting_personOpaleye, L.P.
Fund holding 931,000 shares, beneficially owned.
- reporting_personOpaleye Management Inc.
Investment adviser, deemed to share voting and dispositive power.
- reporting_personJames Silverman
Controlling person of the adviser, deemed to share voting and dispositive power.
